# Phase II Study for Solid Metastatic Tumors

> **NCT02474186** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 41 (actual)

## Conditions studied

- Breast Cancer
- Metastatic Breast Cancer
- Solid Tumor

## Interventions

- **RADIATION:** Radiation therapy
- **DRUG:** Xeloda
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT02474186
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02474186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02474186, "Phase II Study for Solid Metastatic Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02474186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*